ENA 2020 is the drug development and translational research meeting, focusing on preclinical and phase I studies, enabling and facilitating in-depth scientific discussions on the latest developments in targets and drugs.

Attracting academics, scientists and pharmaceutical industry representatives from across the globe to discuss the latest innovations in drug development, target selection and the impact of new discoveries in molecular biology.

ENA is at the forefront of cancer drug development meetings

Presentation of ground-breaking new data

Networking opportunities with world leading experts

Influencing future clinical cancer research to improve survival and
quality of life of cancer patients.

Programme

Sir Peter Ratcliffe, 2019 Nobel Prize Winner
to present Michel Clavel Lecture…

With ground-breaking new data presentations and unrivalled networking opportunities with world leading experts, ENA 2020 allows you to join in and influence the discussion on the future of translational and clinical cancer research.

Michael Clavel Lecture: Sir Peter Ratcliffe (UK)
Keynote Lecture: Toni Choueiri (USA)

Please Note: The programme is subject to change.

Key Dates

ABSTRACT SUBMISSION
UNTIL 24 JUNE

LATE BREAKING ABSTRACT
FROM 17 – 24 SEPT

FREE REGISTRATION
ENA presentation

Sponsorship and Exhibition

The ENA Symposium offers exciting opportunities to achieve the highest level of exposure to academics, scientists and pharmaceutical industry representatives from across the globe.

Partners